Tokyo, March 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060891) titled 'Molecular analysis of retinal diseases using aqueous humor obtained during intravitreal injection' on March 10.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu university school of medicine
Condition:
Condition - Retinal diseases requiring intravitreal injection (e.g., age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and neovascular glaucoma).
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to perform omics analyses, including mRNA and protein analyses, using samples collected without additional invasive procedures from patients with retinal diseases requiring treatment with intravitreal injection (e.g., age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and neovascular glaucoma), in order to contribute to the development of future therapeutic and preventive strategies.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who visited the institutions participating in this study for the purpose of examination and treatment for the target disease and gave their consent
Key exclusion criteria - Patients who did not give consent
Target Size - 768
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 02 Month 27 Day
Anticipated trial start date - 2026 Year 03 Month 10 Day
Last follow-up date - 2031 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069663
Disclaimer: Curated by HT Syndication.
